TAIWAN · TWSE / TPEx
HMDBIO
厚美德 · 6660 · Emerging Stock Board · Biotech and medical
Directors and supervisors hold6,124,28714.4% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold1,778,6964.2% of shares issued
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 翟永萍 | Chairman · Major shareholder (10%+) | 3,057,696 | 1,778,696 | 4.17% | — | 1,585,936 |
| 陳威宇 | Director | 1,570,482 | 1,570,482 | 3.68% | — | — |
| 簡瑞峰 | Director | 677,130 | 677,130 | 1.59% | — | — |
| 緹美投資有限公司 | Director | 2,097,979 | 2,097,979 | 4.92% | — | — |
| 徐可桓 | Director (corporate representative) · Other | — | 318,438 | 0.75% | — | 2,014,947 |
| 何橈通 | Independent director | — | 0 | — | — | — |
| 張恒雄 | Independent director | — | 0 | — | — | — |
| 黃聯聰 | Independent director | — | 0 | — | — | — |
| 徐睿延 | President | — | 375,660 | 0.88% | — | 369,031 |
| 陳秀文 | Chief financial officer · Chief accountant | — | 260,703 | 0.61% | — | — |